HTB homepage • Conference reports • Articles by subject • Subscribe December 2007 Contents Editorial Volume 8 Number 11/12 November/December 2007 Conference reports 11th European AIDS conference (EACS), October 24-27 2007, Madrid New European guidelines launched (2007) Saquinavir/r non-inferior to Kaletra at week 48 (Gemini study) Darunavir once-daily is non-inferior to lopinavir/r in treatment-naive patients at 48 weeks (Artemis study) Tesamorelin (TH9507) reduces abdominal fat in patients with HIV-related lipodystrophy: 52 week results Drug interaction studies presented at EACS Antiretrovirals Half-dose Kaletra tablet approved for paediatric use in the US Treatment access HIV and TB co-infection and treatment charges in the UK Pregnancy US updates guidelines on use of ARVs during pregnancy (Dec 2007) Perinatal transmission of HIV in England 2002-2005 Risk factors for in utero or intrapartum mother-to-child transmission in Thailand PK and drug interactions New drug interaction summary tables: maraviroc, integrase inhibitors, etravirine, hormonal contraceptives Acid reducing agents and protese inhibitors Atazanavir, with or without ritonavir, may increase buprenorphine and buprenorphine metabolites, requiring dose adjustment T-20 increases tipranavir levels but not hepatotoxicity The effect of lopinavir/r on the renal clearance of tenofovir Guidelines US adult treatment guidelines updated (December 2007) Side effects Case report of efavirenz-associated nephrolithiasis Vaccines and microbicides Merck HIV vaccine trial is unblinded Other news IAS statement on US policy for HIV-positive visitors On the web PLoS Medicine articles HIV/TB co-infection: meeting the challenge PDFs Volume 8 Number 11/12 November/December 2007 PDF HTB homepage • Conference reports • Articles by subject • Subscribe